Good morning :)
$
₹
Merit Medical Systems Inc

Merit Medical Systems Inc

MMSI

NASDAQ
Asset Logo

Merit Medical Systems Inc

MMSI

NASDAQ
$89.621.10% (-1.00)
$
₹
$89.621.10% (-1.00)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Medical Instruments & Supplies

Mid Cap

With a market cap of $5.0B the stock is ranked 1459

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

31.52
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

2.89
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$2.67
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

1.52
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

9.94%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 12 analysts reports

Buy
9 analysts
Hold
3 analysts
Sell
0 analyst

Price Upside

+19.39%

Earnings Growth

+13.6%

Rev. Growth

+8.23%

See Detailed Forecast

Company Profile

Company Profile

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; kits and accessories for endoscopy and bronchoscopy procedures; and temporary pacing technology. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; kits and accessories for endoscopy and bronchoscopy procedures; and temporary pacing technology. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Medline Inc. Class A Common Stock
MDLN
M
P/E Ratio
85.22
85.22
1Y Return
3.02%
3.02%
Buy Reco %
85.18
85.18
West Pharmaceutical Services Inc
WST
West Pharmaceutical Services Inc
P/E Ratio
45.67
45.67
1Y Return
38.53%
38.53%
Buy Reco %
93.75
93.75
The Cooper Companies, Inc
COO
The Cooper Companies, Inc
P/E Ratio
21.04
21.04
1Y Return
6.47%
6.47%
Buy Reco %
35.29
35.29
Align Technology Inc
ALGN
Align Technology Inc
P/E Ratio
22.45
22.45
1Y Return
20.18%
20.18%
Buy Reco %
50.00
50.00
Bausch + Lomb Corp
BLCO
Bausch + Lomb Corp
P/E Ratio
—
—
1Y Return
30.95%
30.95%
Buy Reco %
46.66
46.66
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Higher price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 19.39% growth, versus a trailing 3-year CAGR of 8.00%.

2026
Current$89.62Baseline
Analyst Target - 1 year
Target$107+19.39%

All values in $

202220232024202520262027$77.09$90.63$104.16Target+19.39%
2026
Current$89.62Baseline
Analyst Target - 1 year
Target$107+19.39%

All values in $

Revenue Forecast

Revenue Forecast

Lower revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 8.23% growth, versus a trailing 3-year CAGR of 9.59%.

2025
Current$1.51Baseline
Forecast for Dec 2026
High$1.64+8.47%
Average$1.63+8.23%
Low$1.63+8.15%

All values in $ Billion

2021202220232024202520261.071.151.251.351.51Low+8.15%Average+8.23%High+8.47%
2025
Current$1.51Baseline
Forecast for Dec 2026
High$1.64+8.47%
Average$1.63+8.23%
Low$1.63+8.15%

All values in $ Billion

Earnings Per Share Forecast

Earnings Per Share Forecast

Higher earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 13.60% growth, versus a trailing 3-year CAGR of 12.50%.

2025
Current$3.83Baseline
Forecast for Dec 2026
High$4.36+13.84%
Average$4.35+13.6%
Low$4.34+13.32%

All values in $

2021202220232024202520262.372.693.013.483.83Low+13.32%Average+13.6%High+13.84%
2025
Current$3.83Baseline
Forecast for Dec 2026
High$4.36+13.84%
Average$4.35+13.6%
Low$4.34+13.32%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

394.1
38
381.8
40.9
418.8
38.8
416.2
42.3
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Revenue
Net Income
Financial YearQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Total Revenue338339.84355.15354.33381.95384.26394.18381.87418.84416.24
Net Income35.7228.4427.9430.1432.5827.753840.9938.8042.31
Net Profit Margin10.56%8.36%7.86%8.50%8.53%7.22%9.64%10.73%9.26%10.16%
See CostsAll values in $ Million

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Instruments & Supplies

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Merit Medical Systems Inc 31.522.891.52
Medline Inc. Class A Common Stock85.222.55-
West Pharmaceutical Services Inc45.679.572.96
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare MMSI with any stock or ETF
Compare MMSI with any stock or ETF
Comparing from
MMSI
MDLN
WST
Loading...

Frequently asked questions

  1. Merit Medical Systems Inc (MMSI) share price today is $89.62 as of November 6, 2026 at 2:29 AM IST. The stock touched a day high of $91.94 and a day low of $88.81.

  2. Merit Medical Systems Inc stock trades on NASDAQ under the ticker symbol MMSI.

  3. Merit Medical Systems Inc's market capitalization is $5.04B as of November 6, 2026 at 2:29 AM IST.

  4. Merit Medical Systems Inc's price-to-earnings (P/E) ratio is 31.52 as of November 5, 2026.

  5. Merit Medical Systems Inc's price-to-book (P/B) ratio is 2.89 as of November 5, 2026.

  6. Yes, You can buy Merit Medical Systems Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Merit Medical Systems Inc shares in three steps: 1. Search Merit Medical Systems Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Merit Medical Systems Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Merit Medical Systems Inc (MMSI) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.1115 shares at the current price of $89.62.

Loading...